Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction.
Marx N, Rydén L, Federici M, Marx-Schütt K, Verket M, Müller-Wieland D, Gerstein HC, Chan J, Cosentino F, Holman RR, Mellbin L, Ray KK, Standl E, Verma S, Wood D, Tuomilehto J, De Caterina R.
Marx N, et al. Among authors: federici m.
Eur Heart J. 2024 Dec 23;45(48):5117-5126. doi: 10.1093/eurheartj/ehae533.
Eur Heart J. 2024.
PMID: 39387537